The prevention stage of NR-586 asks you to write about screening as a program rather than as a test. Levels of prevention give you the vocabulary: primary work stops the condition from arising, secondary work finds it earlier than symptoms would, tertiary work limits the damage once it exists. Screening lives in the secondary layer and carries arithmetic of its own, because a test's sensitivity and specificity are fixed properties while its predictive value moves with how common the condition is in the group being tested. Your section may print this as NR 586 or NR586; it is the same course. Chamberlain publishes no syllabi outside Canvas. The placement here is our teaching judgment from the course's catalog arc; your section's rubric decides what your week actually asks.
What NR-586 Week 5 asks for
Why does a well-run screening drive sometimes make a clinic worse off? A community health center runs a Saturday screening event and identifies sixty-one people with an abnormal result. Everyone counts the day a success. Six weeks later the picture is different: the follow-up appointment queue is eleven weeks long, roughly a third of those sixty-one never came back, and the ones who did are angry that a scary letter was followed by a two-month wait. Nothing about the test was wrong. What was missing was the rest of the program, which is the part this stage grades: the referral pathway, the capacity to absorb the positives, and the plan for the people whose result was falsely alarming.
A screening program is therefore judged on four things at once. Is the condition worth finding early, meaning it has a detectable pre-symptomatic phase and treatment at that phase does more good than treatment later? Is the test acceptable to the people who must accept it, and how does it perform in this population? What happens to a positive result, concretely, including who calls, how fast, and to what appointment? And what does the program cost the people who are screened, counting anxiety, time off work, and the harms of investigating results that turn out to be nothing?
The arithmetic belongs in the written work rather than in a footnote. Sensitivity is the share of people with the condition whom the test correctly flags, and it is what determines how many cases slip past. Specificity is the share of people without the condition whom the test correctly clears, and it is what determines how many people are frightened unnecessarily. Positive predictive value is the question the person in the chair is actually asking, which is what the odds are that a positive result means they have the condition, and it falls as prevalence falls. Screening a low-prevalence group with a very good test still generates a majority of false positives, and being able to write that sentence with numbers under it is the technical core of the stage.
Deliverables here tend to run 1,100 to 1,500 words and often ask you to evaluate an existing screening recommendation or design a program for the population you have been building all session. Where a recommendation is involved, name the issuing body and its grade or strength language accurately, and be careful not to overstate what a recommendation says. Where a discussion post accompanies the paper, write it as final copy, since Canvas does not reopen a submitted post.
The NR-586 Week 5 method, step by step
Six moves for writing a screening program rather than describing a test.
-
Justify the condition before you justify the test
Burden in your population, a detectable early phase, and evidence that earlier treatment changes outcomes. If the third item is weak, the program is weak no matter how good the test is.
-
State sensitivity and specificity with their source
Both are properties measured in a study population, so name the study and note whether its population resembles yours. Performance figures do not travel unchanged into a different setting.
-
Work the predictive value at your prevalence
Build a simple two by two using your population's estimated prevalence and the test characteristics. Show the arithmetic in one line so the reader can check where the false positives come from.
-
Write the referral pathway as a sequence with owners
Who receives the result, who contacts the person, within how long, to what appointment, and what happens if contact fails twice. A pathway with no named actor is a wish.
-
Count the harms honestly
False positives, over-diagnosis of conditions that would never have caused trouble, the cost of follow-up testing, and the loss of trust when a program cannot deliver what it started. Name them and size them where you can.
-
Close on equity of reach, not on totals
A program that screens a thousand people while missing the subgroup with the highest burden has widened a gap. Say who is likely to be reached, who is not, and what specifically closes the difference.
A layout and word budget for a screening program paper
Our frame for this stage, sized for roughly 1,200 to 1,500 words. It is our own outline rather than anything the university issues, and your week's rubric outranks it wherever they disagree. If a two by two table is permitted outside the word count, build it and use the prose to interpret it.
| Section | What belongs in it | Word target |
|---|---|---|
| Level of prevention identified | Where the proposed activity sits, and one sentence on what the adjacent levels would look like for the same condition. | 110 to 140 |
| Case for screening this condition | Local burden with numbers, the pre-symptomatic window, and evidence that earlier treatment helps. | 220 to 270 |
| Test performance | Sensitivity and specificity with their source population, plus how that population compares with yours. | 180 to 220 |
| Predictive value at your prevalence | The two by two worked through, with the expected number of false positives stated in people rather than percentages. | 200 to 250 |
| Pathway and capacity | The route from positive result to definitive care, with owners, timeframes and the capacity to absorb the volume. | 250 to 300 |
| Harms, reach and equity | What the program costs those screened, who it will reach, and what would extend it to those it will not. | 200 to 250 |
Evidence craft for screening writing
Express predictive value in people. Saying the positive predictive value is 12 percent is technically complete and rhetorically inert. Saying that of every hundred positives, roughly twelve have the condition and eighty-eight do not, makes the design problem visible to any reader.
Report the recommendation exactly as issued. Named bodies use specific strength or grade language, and paraphrasing it upward is a scored error. Quote the level accurately, name the body, give the year, and state which age or risk group the recommendation covers.
Keep sensitivity and predictive value in separate sentences. Merging them is the classic confusion of the stage, because one is a property of the test and the other is a property of the test applied to a particular population.
Do not import performance figures across populations silently. A test validated in a referral population that had already been selected for symptoms will look better than it will perform in a general screening setting. One clause naming that difference protects the whole analysis.
Size the follow-up capacity against the expected positives. If your program will generate a predictable number of positives per month, say what that number is and whether the clinic can see them. A screening paper with no capacity arithmetic is a plan for a queue.
Attribute frameworks and levels of prevention. The prevention levels come from a published literature with a history, and naming your source with a year is the difference between using a framework and repeating a phrase.
Five mistakes that cost points in this week's territory
- Confusing sensitivity with predictive value. The most common technical error in the stage and the easiest for a grader to spot.
- No arithmetic at your own prevalence. Quoting a test's published characteristics without applying them to your population skips the analytic work entirely.
- A pathway with no owners or timeframes. Participants will be referred for follow-up is a sentence, not a program.
- Silence about harms. A screening paper that lists only benefits reads as promotional and loses the evaluation row.
- Counting people screened as the outcome. The outcome is what changed for the people who had the condition, not how many were tested.
Before you submit
- The level of prevention is named and justified rather than assumed
- Sensitivity and specificity carry a source and a note on the source population
- Predictive value is worked at your population's prevalence and stated in people
- The referral pathway has named owners and stated timeframes
- Harms and false positives are counted, not just mentioned
- Reach and equity are addressed with a specific measure, not with intent
Building the screening program paper?
Send the rubric and the condition from Canvas. A premium original draft comes back in 24 to 48 hours with the two by two worked at your prevalence, the pathway written with owners and timeframes, and the harms sized honestly, with revisions until the rows read clean.